Unum Group Earnings Call Transcripts
Fiscal Year 2026
-
A $3.8 billion LTC reinsurance deal will reduce exposure by 40%, improve risk profile, and maintain capital strength. The transaction, closing in 2026, is priced consistently with prior deals and supports ongoing shareholder returns.
-
Shareholders elected all director nominees, approved executive compensation, and ratified the auditor. Financial highlights included strong revenue, increased dividends, and major progress in de-risking long-term care exposure through reinsurance. Strategic focus remains on organic growth, digital transformation, and disciplined M&A.
-
Strong Q1 results featured 10% EPS growth, robust U.S. group and Colonial Life performance, and reduced LTC risk exposure. Capital position remains solid with $400M in share buybacks and guidance for 4%-7% top-line and 8%-12% EPS growth reaffirmed.
-
Premium and EPS growth are projected for 2026, with strong capital returns to shareholders and a focus on core business performance. Technology and AI investments are enhancing client experience, while Closed Block results will be reported separately to highlight ongoing operations.
Fiscal Year 2025
-
2025 results reflected strong premium growth and capital returns, but earnings were below expectations due to higher benefits experience. The outlook for 2026 is positive, with 4%-7% premium growth, 8%-12% EPS growth, and continued robust capital deployment, supported by digital investments and risk reduction in the Closed Block.
-
Core business delivered strong premium growth and robust margins, while strategic actions in the closed block increased reserves but reduced future risk and capital needs. Capital position remains strong, supporting $1.3B in shareholder returns for 2025 and continued investment in growth.
-
Growth remains a top priority, supported by digital investments and a focus on customer retention. Group disability and life benefit ratios have stabilized, while Colonial Life and supplemental products show renewed growth. Strong capital and asset strategies enable continued shareholder returns and risk management.
-
Second quarter results showed strong premium growth and persistency, but earnings were pressured by elevated claims in group disability and LTC. Full-year EPS guidance was revised to $8.50, with robust capital and increased share repurchases expected.
-
Core operations delivered strong ROE and premium growth, though EPS was impacted by higher disability claims. Capital and liquidity reached record levels, with robust sales in voluntary benefits and international growth led by Poland. LTC reinsurance transactions are set to release significant capital.
-
Workplace insurance operations are driving consistent premium and earnings growth, with strong international expansion and improved group disability margins. Recent LTC risk transfer and internal restructuring have released capital, supporting share repurchases, M&A, and dividends. Investor focus is shifting to core business strengths as LTC concerns recede.
-
A major LTC risk transfer and internal reinsurance will reduce legacy exposure by nearly 20%, generate $100 million in capital benefit, and increase holding company cash by $500 million. EPS growth is now projected at 6%-10% for 2025, with further LTC risk transfer transactions under consideration.
-
Management projects 8%-12% EPS growth and strong capital for 2025, driven by robust group business performance, digital investments, and disciplined pricing. Strategic focus includes scaling dental, vision, and international operations, while pursuing LTC risk transfer and targeted M&A.
Fiscal Year 2024
-
Delivered 10% EPS growth and over 20% ROE in 2024, exceeding expectations, with strong capital generation and no LTC capital needs. 2025 guidance calls for 8%-12% EPS growth, robust free cash flow, and continued investment in digital capabilities and shareholder returns.
-
Q3 results showed robust earnings, strong cash flow, and high persistency, with EPS growth expectations raised to 10%-15% for 2024. Share repurchases are set to reach $1 billion, and all core segments delivered solid performance, especially internationally and in Colonial Life.
-
EPS growth guidance for 2024 was raised to 10%-15% due to strong earnings and favorable claims trends, with premium growth and capital generation supporting increased share repurchases. Group disability and life lines show sustainable improvement, while international and voluntary segments continue to recover.
-
Second quarter 2024 delivered record EPS and strong premium growth, prompting an increased full-year EPS outlook to 10%-15%. Robust segment performance, disciplined capital management, and favorable market conditions support continued momentum.